NRx Pharma

NRx Pharma The U.S.

We are NRx – a pioneering and focused CNS biopharma company, dedicated to meeting unmet medical needs for those with suicidal depression, suicidal bipolar depression, and post-traumatic stress disorder (PTSD). Food and Drug Administration (“FDA”) has additionally granted Breakthrough Therapy designation, a Special Protocol Agreement, and a Biomarker Letter of Support for NRX-101, an investigational medicine for the treatment of severe bipolar depression in patients with acute suicidal ideation and behavior (ASIB) after initial stabilization with ketamine or other effective therapy. NRx Pharmaceuticals is led by executives who have held leadership roles at Lilly, Pfizer, and Novartis as well as major investment banking institutions.

NRx Pharmaceuticals (NASDAQ: NRXP) Announces Expanded Access Policy for NRX-100 Following FDA Fast Track Designation -Ya...
08/28/2025

NRx Pharmaceuticals (NASDAQ: NRXP) Announces Expanded Access Policy for NRX-100 Following FDA Fast Track Designation -Yahoo Finance

Read More - https://finance.yahoo.com/news/nrx-pharmaceuticals-nasdaq-nrxp-announces-190000482.html?guccounter=1

$NRXP

LOS ANGELES, CA - August 27, 2025 (NEWMEDIAWIRE) - NRx Pharmaceuticals (NASDAQ: NRXP), a clinical-stage biopharmaceutical company, announced its expanded access policy for NRX-100 (preservative-free ketamine) after receiving FDA Fast Track designatio...

08/26/2025

Your Voice Counts. Your Impact Can Change Lives. 💙

presents Voice of the Patient: "Offer Hope. Offer Help. Join the Movement."
📅 September 15, 2025

This is more than an event, it’s a chance to be heard, share your story, and help shape the future of care for patients and families everywhere.

✨ Together, patients, caregivers, and innovators can create real change.

👉🏻Sign up now: http://forum.nrxpharma.com?utm_source=newtothestreet&=

Watch the latest New to The Street interview here👇🏻👇🏻👇🏻
https://ow.ly/RCnB50WCfsc

🔗 Learn more at https://www.nrxpharma.com/?utm_source=newtothestreet&=c

New analyst report from BTIG - NRX Pharmaceuticals Inc (NRXP, Buy, $25 PT): 2Q25 Update. Progress on Most Fronts. FDA Ac...
08/25/2025

New analyst report from BTIG - NRX Pharmaceuticals Inc (NRXP, Buy, $25 PT): 2Q25 Update. Progress on Most Fronts. FDA Acceptance for the NDA Detailing

Read Report -https://www.nrxpharma.com/wp-content/uploads/2025/08/2Q25-Update.-Progress-on-Most-Fronts.-FDA-Acceptance-for-the.pdf

New analyst report from D. Boral Capital - Raising Probability of Success on Ketamine Franchise; Target Price to $34.0 f...
08/22/2025

New analyst report from D. Boral Capital - Raising Probability of Success on Ketamine Franchise; Target Price to $34.0 from $31.0

Read Report -https://www.nrxpharma.com/wp-content/uploads/2025/08/NRx-Pharmaceuticals_-Raising-Probability-of-Success-on-Ketam.pdf

NRx Pharmaceuticals (NASDAQ: NRXP) Reports Q2 2025 Results, Highlights Progress Across Lead Programs -Yahoo FinanceRead ...
08/21/2025

NRx Pharmaceuticals (NASDAQ: NRXP) Reports Q2 2025 Results, Highlights Progress Across Lead Programs -Yahoo Finance

Read More - https://finance.yahoo.com/news/nrx-pharmaceuticals-nasdaq-nrxp-reports-170000125.html

LOS ANGELES, CA - August 19, 2025 (NEWMEDIAWIRE) - NRx Pharmaceuticals (NASDAQ: NRXP), a clinical-stage biopharmaceutical company, reported financial results for the quarter ended June 30, 2025, and provided a corporate update. The Company highlighte...

Address

1201 N Market Street, Suite 111
Wilmington, DE
19801

Website

Alerts

Be the first to know and let us send you an email when NRx Pharma posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Practice

Send a message to NRx Pharma:

Shortcuts

Share

Share on Facebook Share on Twitter Share on LinkedIn
Share on Pinterest Share on Reddit Share via Email
Share on WhatsApp Share on Instagram Share on Telegram

Category